![](/img/cover-not-exists.png)
Multicenter phase II study of combination therapy with cetuximab and S-1 in patients withKRASexon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study)
Takahashi, Takao, Emi, Yasunori, Oki, Eiji, Kobayashi, Kazuma, Tsuji, Akihito, Shimokawa, Mototsugu, Tanaka, Takaho, Akagi, Yoshito, Ogata, Yutaka, Baba, Hideo, Yoshida, Kazuhiro, Natsugoe, Shoji, MaeVolume:
78
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-016-3109-4
Date:
September, 2016
File:
PDF, 607 KB
english, 2016